Shopping Cart 0
Cart Subtotal
USD 0

Parexel International Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.

Parexel International Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10

Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Parexel International Corp, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Pamplona Capital Management Acquires Parexel International for USD5 Billion 12

Partnerships 14

Parexel Enters into Agreement with Microsoft 14

Parexel Enters into Agreement with Osaka International Cancer 15

InDex Pharma Enters into Agreement with Parexel 16

Polus Enters into Agreement with Parexel 17

Parexel International Enters Into Agreement With National Taiwan University Hospital 18

Debt Offering 19

Parexel International Completes Private Placement Of Notes Due 2020 For USD 100 Million 19

Acquisition 20

Parexel International Acquires Medical Affairs Company 20

Parexel International Acquires Quantum Solutions, Contract Research Organization 21

Parexel Acquires ClinIntel 22

Parexel International Acquires Atlas Medical 23

Parexel Acquires Heron Group For USD37 Million 24

Parexel International Acquires Liquent For USD74.3 Million 25

Parexel International Corp-Key Competitors 26

Parexel International Corp-Key Employees 27

Parexel International Corp-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 33

Financial Announcements 33

Aug 28, 2017: PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results 33

May 03, 2017: PAREXEL International Reports Third Quarter Fiscal Year 2017 Results 34

Feb 01, 2017: PAREXEL International Reports Second Quarter Fiscal Year 2017 Results 36

Corporate Communications 38

Nov 12, 2018: Parexel announces appointment of new members to its Board of Directors 38

Aug 16, 2018: PAREXEL announces appointment of two key executives 40

Apr 25, 2018: PAREXEL Names Peyton Howell as Chief Commercial and Strategy Officer 41

Mar 05, 2018: PAREXEL Names Jamie Macdonald As Chief Executive Officer 42

Feb 28, 2017: PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer 43

Government and Public Interest 44

May 15, 2018: CRO Industry Update: Big Data Drives Drug Development Efforts 44

Other Significant Developments 47

Oct 31, 2018: PAREXEL navigates China's complex drug development and market landscape for global biopharmaceutical companies with new China Advisory Service 47

Sep 11, 2018: PAREXEL advances patient-centric drug development with introduction of its patient innovation center 48

Mar 21, 2018: PAREXEL Introduces Integrated Medical Writing Solutions Service Offering 49

Feb 12, 2018: PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development 50

Sep 06, 2017: PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments 51

Jun 19, 2017: PAREXEL Introduces Its Connected Journey of Newly Integrated Data-Driven Services to Simplify Drug Development and Commercialization 52

Appendix 53

Methodology 53

About GlobalData 53

Contact Us 53

Disclaimer 53


List Of Figure

List of Figures

Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Parexel International Corp, Pharmaceuticals & Healthcare, Key Facts 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Parexel International Corp, Deals By Therapy Area, 2012 to YTD 2018 9

Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10

Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Pamplona Capital Management Acquires Parexel International for USD5 Billion 12

Parexel Enters into Agreement with Microsoft 14

Parexel Enters into Agreement with Osaka International Cancer 15

InDex Pharma Enters into Agreement with Parexel 16

Polus Enters into Agreement with Parexel 17

Parexel International Enters Into Agreement With National Taiwan University Hospital 18

Parexel International Completes Private Placement Of Notes Due 2020 For USD 100 Million 19

Parexel International Acquires Medical Affairs Company 20

Parexel International Acquires Quantum Solutions, Contract Research Organization 21

Parexel Acquires ClinIntel 22

Parexel International Acquires Atlas Medical 23

Parexel Acquires Heron Group For USD37 Million 24

Parexel International Acquires Liquent For USD74.3 Million 25

Parexel International Corp, Key Competitors 26

Parexel International Corp, Key Employees 27

Parexel International Corp, Other Locations 28

Parexel International Corp, Subsidiaries 29

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Parexel International Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Parexel International Corp (Parexel) is a biopharmaceutical outsourcing service company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.

Parexel International Corp-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10

Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Parexel International Corp, Pharmaceuticals & Healthcare, Deal Details 12

Private Equity 12

Pamplona Capital Management Acquires Parexel International for USD5 Billion 12

Partnerships 14

Parexel Enters into Agreement with Microsoft 14

Parexel Enters into Agreement with Osaka International Cancer 15

InDex Pharma Enters into Agreement with Parexel 16

Polus Enters into Agreement with Parexel 17

Parexel International Enters Into Agreement With National Taiwan University Hospital 18

Debt Offering 19

Parexel International Completes Private Placement Of Notes Due 2020 For USD 100 Million 19

Acquisition 20

Parexel International Acquires Medical Affairs Company 20

Parexel International Acquires Quantum Solutions, Contract Research Organization 21

Parexel Acquires ClinIntel 22

Parexel International Acquires Atlas Medical 23

Parexel Acquires Heron Group For USD37 Million 24

Parexel International Acquires Liquent For USD74.3 Million 25

Parexel International Corp-Key Competitors 26

Parexel International Corp-Key Employees 27

Parexel International Corp-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 33

Financial Announcements 33

Aug 28, 2017: PAREXEL International Reports Fourth Quarter and Fiscal Year 2017 Results 33

May 03, 2017: PAREXEL International Reports Third Quarter Fiscal Year 2017 Results 34

Feb 01, 2017: PAREXEL International Reports Second Quarter Fiscal Year 2017 Results 36

Corporate Communications 38

Nov 12, 2018: Parexel announces appointment of new members to its Board of Directors 38

Aug 16, 2018: PAREXEL announces appointment of two key executives 40

Apr 25, 2018: PAREXEL Names Peyton Howell as Chief Commercial and Strategy Officer 41

Mar 05, 2018: PAREXEL Names Jamie Macdonald As Chief Executive Officer 42

Feb 28, 2017: PAREXEL International Appoints Simon Harford as Senior Vice President and Chief Financial Officer 43

Government and Public Interest 44

May 15, 2018: CRO Industry Update: Big Data Drives Drug Development Efforts 44

Other Significant Developments 47

Oct 31, 2018: PAREXEL navigates China's complex drug development and market landscape for global biopharmaceutical companies with new China Advisory Service 47

Sep 11, 2018: PAREXEL advances patient-centric drug development with introduction of its patient innovation center 48

Mar 21, 2018: PAREXEL Introduces Integrated Medical Writing Solutions Service Offering 49

Feb 12, 2018: PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development 50

Sep 06, 2017: PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments 51

Jun 19, 2017: PAREXEL Introduces Its Connected Journey of Newly Integrated Data-Driven Services to Simplify Drug Development and Commercialization 52

Appendix 53

Methodology 53

About GlobalData 53

Contact Us 53

Disclaimer 53


List Of Figure

List of Figures

Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Parexel International Corp, Pharmaceuticals & Healthcare, Key Facts 2

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Parexel International Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Parexel International Corp, Deals By Therapy Area, 2012 to YTD 2018 9

Parexel International Corp, Medical Devices Deals, 2012 to YTD 2018 10

Parexel International Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Pamplona Capital Management Acquires Parexel International for USD5 Billion 12

Parexel Enters into Agreement with Microsoft 14

Parexel Enters into Agreement with Osaka International Cancer 15

InDex Pharma Enters into Agreement with Parexel 16

Polus Enters into Agreement with Parexel 17

Parexel International Enters Into Agreement With National Taiwan University Hospital 18

Parexel International Completes Private Placement Of Notes Due 2020 For USD 100 Million 19

Parexel International Acquires Medical Affairs Company 20

Parexel International Acquires Quantum Solutions, Contract Research Organization 21

Parexel Acquires ClinIntel 22

Parexel International Acquires Atlas Medical 23

Parexel Acquires Heron Group For USD37 Million 24

Parexel International Acquires Liquent For USD74.3 Million 25

Parexel International Corp, Key Competitors 26

Parexel International Corp, Key Employees 27

Parexel International Corp, Other Locations 28

Parexel International Corp, Subsidiaries 29

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Parexel International Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.